Clinical Trials Browser

Interventional × Carcinoma, Renal Cell × Selenomethionine × Clear all

NCT05363631 2025-12-10

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Phase 1/2 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell